Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

391 publications
Année de publication :
Réseaux :

Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with…

Small Conductance Calcium (Ca2+)-activated potassium (K+) channels (SKCa) are now proved to be involved in many cancer cell behaviors such as proliferation or migration. The SK3 channel isoform was particularly described in breast cancer where it can be associated with the Orai1 Ca2+ channel to form a complex…

  • Ref: doi: 10.1016/j.ejmech.2019.111854
  • Année de publication : 2020
  • Auteurs : Kouba S, Braire J, Félix R, Chantôme A, Jaffrès PA, Lebreton J, Dubreuil D, Pipelier M, Zhang X, Trebak M, Vandier C, Mathé-Allainmat M, Potier-Cartereau M.
  • Réseaux : Réseaux: « Molécules Marines, Métabolisme et Cancer »
Lire la publication

Molecular classification of cholangiocarcinoma.

Purpose of review: Cholangiocarcinoma (CCA) are heterogeneous tumors that arise from the malignant transformation of cholangiocytes along the biliary tree. CCA heterogeneity occurs at multiple levels and results in resistance to therapy and poor prognosis.

  • Ref: DOI: 10.1097/MOG.0000000000000611
  • Année de publication : 2020
  • Auteurs : Corentin Louis , Panagiotis Papoutsoglou, Cédric Coulouarn
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

Interobserver agreement of 18F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in…

Declaration of competing interest Dr. Le Gal reports grants from Portola Pharmaceuticals; was a co-investigator for trials conducted by Boehringer Ingelheim, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Leo Pharma, Daiichi Sankyo, and Bayer; and received honoraria from Bayer, Pfizer, GlaxoSmithKline, LEO Pharma Research Foundation, Sanofi, and bioMerieux, outside the submitted work.

  • Ref: doi: 10.1016/j.thromres.2020.01.028
  • Année de publication : 2020
  • Auteurs : Robin P, Grewal RK, Le Roux PY, Le Gal G, Salaun PY.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate…

Adjuvant radiotherapy after prostatectomy was recently challenged by early salvage radiotherapy, which highlighted the need for biomarkers to improve risk stratification. Therefore, we developed an MRI ADC map-derived radiomics model to predict biochemical recurrence (BCR) and BCR-free survival (bRFS) after surgery. Our goal in this work was to externally validate this radiomics-based prediction model.

  • Ref: doi: 10.3390/cancers12040814
  • Année de publication : 2020
  • Auteurs : Bourbonne V, Fournier G, Vallières M, Lucia F, Doucet L, Tissot V, Cuvelier G, Hue S, Le Penn Du H, Perdriel L, Bertrand N, Staroz F, Visvikis D, Pradier O, Hatt M, Schick U.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Kilovoltageintrafraction monitoring during normofractionated prostate cancer radiotherapy.

During radiotherapy (RT) for prostate cancer (PCa), interfraction and intrafraction movements can lead to decreased target dose coverage and unnecessary over-exposure of organs at risk.

  • Ref: doi: 10.1016/j.canrad.2019.11.001
  • Année de publication : 2020
  • Auteurs : Chasseray M, Dissaux G, Lucia F, Boussion N, Goasduff G, Pradier O, Bourbonne V, Schick U.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Haute Couture or Ready-to-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node…

Prostate cancer (PCa) pelvic radiotherapy fields are defined by guidelines that do not consider individual variations in lymphatic drainage.

  • Ref: doi: 10.3390/cancers12040944
  • Année de publication : 2020
  • Auteurs : Michaud AV, Samain B, Ferrer L, Fleury V, Doré M, Colombié M, Dupuy C, Rio E, Guimas V, Rousseau T, Le Thiec M, Delpon G, Rousseau C, Supiot S.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of…

To perform bladder dose-surface map (DSM) analysis for (1) identifying symptom-related sub-surfaces (Ssurf) and evaluating their prediction capability of urinary toxicity, (2) comparing DSM with dose-volume map (DVM) (method effect), and (3) assessing the reproducibility of DSM (cohort effect).

  • Ref: doi: 10.1016/j.radonc.2020.02.028
  • Année de publication : 2020
  • Auteurs : Mylona E, Cicchetti A, Rancati T, Palorini F, Fiorino C, Supiot S, Magne N, Crehange G, Valdagni R, Acosta O, de Crevoisier R.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Secretion of acid sphingomyelinase and ceramide by endothelial cells contributes to radiation-induced intestinal toxicity.

Ceramide-induced endothelial cell apoptosis boosts intestinal stem cell radiosensitivity. However, the molecular connection between these two cellular compartments has not been clearly elucidated.

  • Ref: doi: 10.1158/0008-5472.CAN-19-1527
  • Année de publication : 2020
  • Auteurs : Leonetti D, Estéphan H, Ripoche N, Dubois N, Aguesse A, Gouard S, Brossard L, Chiavassa S, Corre I, Pecqueur C, Neunlist M, Hadchity E, Gaugler MH, Mahé MM, Paris F.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Towards a Stronger Halogen Bond Involving Astatine: Unexpected Adduct with Bu3 PO Stabilized by Hydrogen Bonding.

The halogen bond is a powerful tool for the molecular design and pushing the limits of its strength is of major interest. Bearing the most potent halogen-bond donor atom, astatine monoiodide (AtI) was recently successfully probed [Nat. Chem. 2018, 10, 428-434].

  • Ref: doi: 10.1002/chem.201905389
  • Année de publication : 2020
  • Auteurs : Liu L, Guo N, Champion J, Graton J, Montavon G, Galland N, Maurice R.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication